| |
| |
|
| Insider
Information: |
Winger Dennis L |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
288,465 |
|
|
Indirect Shares
|
11,500 |
|
|
| Direct
Value |
$3,671,894 |
|
|
|
Indirect Value
|
$2,873,160 |
|
|
| Total
Shares |
299,965 |
|
|
| Total
Value |
$6,545,054 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Applera-Applied Biosys |
ABI |
Senior Vice President ... |
2008-11-21 |
0 |
2003-07-11 |
0 |
Premium* |
|
|
Heron Therapeutics Inc |
HRTX |
Director |
2006-08-11 |
69,544 |
2003-07-25 |
0 |
Premium* |
|
|
Vertex Pharmaceuticals Inc |
VRTX |
Director |
2012-03-09 |
6,500 |
2010-02-16 |
6,500 |
Premium* |
|
|
Accuray Inc |
ARAY |
Director |
2017-11-30 |
162,181 |
2010-11-30 |
0 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
Director |
2018-08-21 |
42,750 |
2018-08-21 |
5,000 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2017-06-14 |
7,490 |
2014-12-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
• – – |
2008-11-17 |
4 |
S |
$29.20 |
$10,963,065 |
D/D |
(375,423) |
131,720 |
0 |
- |
|
| ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
• – – |
2008-11-17 |
4 |
OE |
$15.54 |
$9,361,250 |
D/D |
438,860 |
507,143 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2012-03-09 |
4 |
D |
$41.65 |
$1,613,938 |
D/D |
(38,750) |
6,500 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2012-03-09 |
4 |
A |
$34.05 |
$1,323,238 |
D/D |
38,750 |
45,250 |
0 |
- |
|
| ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
• – – |
2007-08-01 |
4 |
S |
$30.69 |
$1,061,266 |
D/D |
(34,449) |
79,171 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-08-13 |
4 |
S |
$61.04 |
$1,045,310 |
D/D |
(17,125) |
59,875 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-08-14 |
4 |
S |
$60.15 |
$1,030,069 |
D/D |
(17,125) |
42,750 |
0 |
- |
|
| ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
• – – |
2007-08-03 |
4 |
S |
$31.42 |
$1,007,600 |
D/D |
(31,938) |
81,683 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-08-21 |
4 |
S |
$60.30 |
$904,500 |
D/D |
(15,000) |
42,750 |
0 |
- |
|
| ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
• – – |
2007-08-02 |
4 |
S |
$31.53 |
$898,488 |
D/D |
(28,352) |
85,268 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-08-17 |
4 |
S |
$59.62 |
$894,300 |
D/D |
(15,000) |
42,750 |
0 |
- |
|
| ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
• – – |
2007-08-01 |
4 |
OE |
$16.11 |
$788,498 |
D/D |
46,319 |
113,620 |
0 |
- |
|
| ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
• – – |
2007-08-03 |
4 |
OE |
$16.11 |
$746,132 |
D/D |
46,320 |
113,621 |
0 |
- |
|
| ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
• – – |
2007-08-02 |
4 |
OE |
$16.11 |
$746,116 |
D/D |
46,319 |
113,620 |
0 |
- |
|
| ABI |
Applera-Applied Biosys |
officerTitle |
• – – |
2006-02-01 |
4 |
S |
$28.10 |
$667,461 |
D/D |
(23,667) |
76,746 |
|
- |
|
| ABI |
Applera-Applied Biosys |
officerTitle |
• – – |
2006-02-03 |
4 |
S |
$27.41 |
$651,678 |
D/D |
(23,666) |
44,161 |
|
- |
|
| ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
• – – |
2006-05-02 |
4 |
S |
$28.42 |
$617,715 |
D/D |
(21,667) |
34,161 |
|
- |
|
| ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
• – – |
2007-08-02 |
4 |
S |
$30.89 |
$562,195 |
D/D |
(17,967) |
67,301 |
0 |
- |
|
| ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
• – – |
2006-05-04 |
4 |
S |
$28.94 |
$517,376 |
D/D |
(17,780) |
38,047 |
|
- |
|
| ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
• – – |
2007-08-03 |
4 |
S |
$31.28 |
$450,817 |
D/D |
(14,382) |
67,301 |
0 |
- |
|
| ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
• – – |
2007-11-06 |
4 |
S |
$35.98 |
$408,733 |
D/D |
(11,297) |
68,090 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-01-04 |
4 |
OE |
$11.97 |
$403,988 |
D/D |
33,750 |
77,000 |
0 |
- |
|
| ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
• – – |
2008-02-06 |
4 |
S |
$31.76 |
$396,777 |
D/D |
(12,450) |
66,937 |
0 |
- |
|
| ABI |
Applera-Applied Biosys |
Senior Vice President and CFO |
• – – |
2007-11-02 |
4 |
S |
$36.18 |
$386,012 |
D/D |
(10,629) |
68,758 |
0 |
- |
|
| ABI |
Applera-Applied Biosys |
officerTitle |
• – – |
2006-02-01 |
4 |
OE |
$16.11 |
$381,233 |
D/D |
23,667 |
100,413 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
